ON THIS PAGE: You will learn about the different types of treatments doctors use for people with pancreatic cancer. Use the menu to see other pages.
This section explains the types of treatments that are the standard of care for pancreatic cancer. “Standard of care” means the best treatments known. These are the treatments that have been shown to be most effective based on evidence-based research conducted in clinical trials on a certain subset of patients.
When making treatment plan decisions, you are encouraged to consider clinical trials as an option. A clinical trial is a research study that tests a new approach to treatment. Doctors want to learn whether the new treatment is safe, effective, and possibly better than the standard treatment. Clinical trials can test a new drug, a new combination of standard treatments, or new doses of standard drugs or other treatments. Clinical trials are an option to consider for treatment and care for all stages of cancer. Your doctor can help you consider all your treatment options. Learn more about clinical trials in the About Clinical Trials and Latest Research sections of this guide.
In cancer care, different types of doctors and other health care professionals often work together to create a patient’s overall treatment plan that combines different types of treatments. This is called a multidisciplinary team. Cancer care teams include a variety of other health care professionals, such as physician assistants, nurse practitioners, oncology nurses, social workers, pharmacists, counselors, dietitians, and others.
Descriptions of the common types of treatments used for pancreatic cancer are listed below, followed by an outline of treatments by stage. The current treatment options for pancreatic cancer are surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Your care plan also includes treatment for symptoms and side effects, an important part of cancer care.
Treatment options and recommendations depend on several factors, including the type and stage of cancer, possible side effects, and the patient’s preferences and overall health. Take time to learn about all of your treatment options and be sure to ask questions about things that are unclear. Talk with your doctor about the goals of each treatment and what you can expect while receiving the treatment. These types of talks are called “shared decision making.” Shared decision making is when you and your doctors work together to choose treatments that fit the goals of your care. Shared decision making is particularly important for pancreatic cancer because there are different treatment options. Learn more about making treatment decisions.
When detected at an early stage, pancreatic cancer has a much higher chance of being successfully treated. However, there are also treatments that can help control the disease for patients with later stage pancreatic cancer to help them live longer.
Surgery for pancreatic cancer includes removing all or part of the pancreas, depending on the location and size of the tumor in the pancreas. An area of healthy tissue around the tumor is also often removed. This is called a margin. A goal of surgery is to have “clear margins” or “negative margins,” which means that there are no cancer cells in the edges of the healthy tissue removed.
A surgical oncologist is a doctor who specializes in treating cancer using surgery. Learn more about the basics of cancer surgery.
Only about 20% of people diagnosed with pancreatic cancer are able to have surgery because most pancreatic cancers are found after the disease has already spread. When surgery is a potential treatment option, there are many things to think about before a surgery of this type. It's important to have a thorough discussion with your doctor before deciding on surgical treatment, including talking about the benefits, risks, and recovery time. If surgery is not an option, you and your doctor will talk about other treatment options.
Surgery for pancreatic cancer may be combined with systemic therapy and/or radiation therapy (see below). Typically, these additional treatments are given after surgery, which is called adjuvant therapy. However, systemic therapy and/or radiation therapy may sometimes be used before surgery to shrink a tumor. This is called neoadjuvant therapy or pre-operative therapy. After neoadjuvant therapy, the tumor is re-staged before planning surgery. Re-staging is usually done with another CT scan to look at the change in tumor size and what nearby structures and blood vessels it is affecting.
Different types of surgery are performed depending on the purpose of the surgery.
Laparoscopy. Sometimes, the surgeon may choose to start with a laparoscopy. During a laparoscopy, several small holes are made in the abdomen and a tiny camera is passed into the body while a patient receives anesthesia. Anesthesia is medication to help block the awareness of pain. During this surgery, the surgeon can find out if the cancer has spread to other parts of the abdomen. If it has, surgery to remove the primary tumor is generally not recommended.
Surgery to remove the tumor. Different types of surgery are used depending on where the tumor is located in the pancreas. In all of the surgeries discussed below, nearby lymph nodes are removed as part of the operation. More than 1 type of surgeon, as well as other specialists, will usually be involved in your surgery.
Whipple procedure. This surgery may be done if the cancer is located only in the head of the pancreas. This is an extensive surgery in which the surgeon removes the head of the pancreas and the part of the small intestine called the duodenum, as well as the bile duct and stomach. Then, the surgeon reconnects the digestive tract and biliary system. A surgeon with experience treating pancreatic cancer should perform this procedure.
Distal pancreatectomy. This surgery is commonly done if the cancer is located in the tail of the pancreas. In this surgery, the surgeon removes the tail and body of the pancreas, as well as the spleen.
Total pancreatectomy. If the cancer has spread throughout the pancreas or is located in many areas in the pancreas, a total pancreatectomy may be needed. A total pancreatectomy is the removal of the entire pancreas, part of the small intestine, a portion of the stomach, the common bile duct, the gallbladder, and the spleen.
After surgery, you will need to stay in the hospital for several days and will probably need to rest at home for about a month. Your health care team will work closely with you on your recovery plan, including providing important dietary and nutritional recommendations.
Side effects of surgery include weakness, tiredness, and pain for the first few days after the procedure. Other side effects caused by the removal of the pancreas include difficulty digesting food and diabetes from the loss of insulin produced by the pancreas. Before surgery, talk with your health care team about the possible side effects from the specific surgery you will have and how they can be managed.
For more information on relieving side effects, see the section entitled "Physical, emotional, and social effects of cancer," below.
Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. The most common type of radiation treatment is called external-beam radiation therapy, which is radiation given from a machine outside the body. Learn more about the basics of radiation therapy.
External-beam radiation therapy is the type of radiation therapy used most often for pancreatic cancer. A radiation therapy regimen, or schedule, usually consists of a specific number of treatments given over a set period of time. There are different ways that radiation therapy can be given:
Traditional radiation therapy. This is also called conventional or standard fraction radiation therapy. It is made up of daily treatments of lower doses of radiation per fraction or day. It is given over 5 to 6 weeks in total.
Stereotactic body radiation (SBRT) or cyberknife. These are shorter treatments of higher doses of radiation therapy given over as few as 5 days. This is a newer type of radiation therapy that can provide more localized treatment in fewer treatment sessions. Whether this approach works as well as traditional radiation therapy is not yet known, and it may not be appropriate for every person. It should only be given in specialized centers with experience and expertise in using this technology for pancreatic cancer and identifying who it will work best for.
Proton beam therapy. This is a type of external-beam radiation therapy that uses protons rather than x-rays. At high energy, protons can destroy cancer cells. It also lessens the amount of healthy tissue that receives radiation. Proton beam therapy may be given for a standard amount of time or for a shorter time like SBRT. It is not yet known whether it works better than standard radiation therapy, and it may not be an option for every person. It should be given in treatment centers that have the experience and skills needed to use this treatment for pancreatic cancer, which may only be available through a clinical trial.
Other types of radiation therapy may also be offered. There are many different ways radiation therapy is given, so it's important to talk with your doctor about their planned approach.
Often, chemotherapy (see below) will be given at the same time as radiation therapy because it can enhance the effects of the radiation therapy, which is called radiosensitization. Combining chemotherapy and radiation therapy may occasionally help shrink the tumor enough so it can be removed by surgery. However, chemotherapy given at the same time as radiation therapy often has to be given at lower doses than when given alone.
Radiation therapy may be helpful for reducing the risk of the pancreatic cancer returning or re-growing in the original location. But there remains much uncertainty as to how much, if at all, it lengthens a person’s life.
Side effects from radiation therapy may include fatigue, mild skin reactions, nausea, upset stomach, and loose bowel movements. Most side effects go away soon after treatment is finished. Talk with your health care team about what you can expect and how side effects will be managed.
Therapies using medication
Systemic therapy is the use of medication to destroy cancer cells. This type of medication is given through the bloodstream to reach cancer cells throughout the body. Systemic therapies are generally prescribed by a medical oncologist, a doctor who specializes in treating cancer with medication.
Common ways to give systemic therapies include an intravenous (IV) tube placed into a vein using a needle or in a pill or capsule that is swallowed (orally).
Chemotherapy is the main type of systemic therapy used for pancreatic cancer. However, targeted therapy and immunotherapy are occasionally used and are being studied as potential treatments (see section on Latest Research).
Each of these types of therapies are discussed below in more detail. A person may receive only 1 type of systemic therapy at a time or a combination of systemic therapies given at the same time. They can also be given as part of a treatment plan that includes surgery and/or radiation therapy.
The medications used to treat cancer are continually being evaluated. Talking with your doctor is often the best way to learn about the medications prescribed for you, their purpose, and their potential side effects or interactions with other medications. It is also important to let your doctor know if you are taking any other prescription or over-the-counter medications or supplements. Herbs, supplements, and other drugs can interact with cancer medications. Learn more about your prescriptions by using searchable drug databases.
Chemotherapy is the use of drugs to destroy cancer cells, usually by keeping the cancer cells from growing, dividing, and making more cells.
A chemotherapy regimen, or schedule, usually consists of a specific number of cycles given over a set period of time. There is usually a rest period in between cycles. A patient may receive 1 drug at a time or a combination of different drugs given at the same time. The following drugs are approved by the U.S. Food and Drug Administration (FDA) for pancreatic cancer:
Erlotinib (Tarceva), a type of targeted therapy (see below)
Nanoliposomal irinotecan (Onivyde)
There are generally more side effects when 2 or more drugs are used together. Combination treatments are usually best for people who are able to carry out their usual activities of daily living without help.
The choice of which combination to use varies depending on the cancer center and often depends on the oncologist’s experience with the drugs, as well as the different side effects and a patient’s overall health. For pancreatic cancer, chemotherapy may be described by when and how it is given:
First-line chemotherapy. This is generally the first treatment used for people with either locally advanced or metastatic pancreatic cancer (see Stages).
Second-line chemotherapy. When the first treatment does not work or stops working to control cancer growth, the cancer is called refractory. Sometimes, first-line treatment does not work at all, which is called primary resistance. Or, treatment may work well for a while and then stop being effective later, which is sometimes called secondary or acquired resistance. In these situations, patients may benefit from additional treatment with different drugs if the patient’s overall health is good. There is significant ongoing research focused on developing other new treatments for second-line, as well as third-line, treatment and beyond. Some of these have shown considerable promise (see the Latest Research section).
Off-label use. This refers to a drug being given for a condition not listed on its label. This means that it is not being given for the condition(s) that the drug is specifically approved for by the FDA. It can also mean that the drug is being given differently than the instructions on the label. An example of this is if your doctor wants to use a drug only approved for breast cancer to treat pancreatic cancer. Using a drug off-label is only recommended when there is solid evidence that the drug may work for another disease not included on the label. This evidence may include previously published research, promising results from ongoing research, or results from molecular tumor testing that suggest that the drug may work. However, off-label use of drugs may not be covered by your health insurance provider. Exceptions are possible, but it is important that you and/or your health care team talk with your insurance provider before this type of treatment begins.
Side effects of chemotherapy
The side effects of chemotherapy depend on which drugs you receive. In addition, not all patients have the same side effects even when given the same drug. Side effects in general can include poor appetite, nausea, vomiting, diarrhea, gastrointestinal problems, rash, mouth sores, hair loss, and a lack of energy. People receiving chemotherapy also are more likely to have low levels of white blood cells, red blood cells, and platelets, which give them a higher risk of anemia, infections, and bruising and bleeding easily.
Certain drugs used in pancreatic cancer are also linked with specific side effects. For example, capecitabine can cause redness and discomfort on the palms of the hands and the soles of the feet. This condition is called hand-foot syndrome. Oxaliplatin can cause cold sensitivity and numbness and tingling in the fingers and toes, called peripheral neuropathy. Peripheral neuropathy is a side effect of nab-paclitaxel as well. These are examples, and it is important to talk with your doctor beforehand about side effects of the cancer medication(s) recommended for you.
Most side effects typically go away between treatments and after the treatments have ended, but some can be longer-lasting and can worsen as treatment continues. Your doctor can suggest ways to relieve these side effects. If the side effects are severe, your doctor may reduce the chemotherapy dose or pause chemotherapy for a short time.
Learn about the basics of chemotherapy.
Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and limits damage to healthy cells.
Not all tumors have the same targets. To find the most effective treatment, your doctor may run tests to identify the genes, proteins, and other factors in your tumor. This helps doctors better match each patient with the most effective treatment whenever possible. In addition, research studies continue to find out more about specific molecular targets and new treatments directed at them.
Erlotinib (Tarceva) is approved by the FDA for people with advanced pancreatic cancer in combination with the chemotherapy drug gemcitabine. Erlotinib blocks the effect of the epidermal growth factor receptor (EGFR), a protein that can become abnormal and help cancer grow and spread. The side effects include a skin rash similar to acne, diarrhea, and fatigue.
Olaparib (Lynparza) is approved for people with metastatic pancreatic cancer associated with a germline (hereditary) BRCA mutation. It is intended for use as maintenance therapy after a patient has been on platinum-based chemotherapy, such as oxaliplatin or cisplatin, for at least 16 weeks with no evidence of disease progression.
Larotrectinib (Vitrakvi) is a tumor-agnostic treatment that can be used for any type of cancer that harbors a specific genetic change called an NTRK fusion (see Diagnosis). This type of genetic change is found in a range of cancers, including pancreatic cancer, though it is rare. It is approved as a treatment for pancreatic cancer that is metastatic or locally advanced and has not responded to chemotherapy.
Talk with your doctor about possible side effects for a specific medication and how they can be managed.
Learn more about the basics of targeted treatments.
Immunotherapy, also called biologic therapy, is designed to boost the body's natural defenses to fight the cancer. It uses materials made either by the body or in a laboratory to improve, target, or restore immune system function.
Immune checkpoint inhibitors, which include anti-PD-1 antibodies such as pembrolizumab (Keytruda), are an option for treating pancreatic cancers that have high microsatellite instability (MSI-H) (see Diagnosis). Approximately 1% to 1.5% of pancreatic cancers are associated with high MSI-H.
Different types of immunotherapy can cause different side effects. Common side effects include skin reactions, flu-like symptoms, diarrhea, and weight changes. Talk with your doctor about possible side effects of the immunotherapy recommended for you. Learn more about the basics of immunotherapy.
Physical, emotional, and social effects of cancer
Cancer and its treatment cause physical symptoms and side effects, as well as emotional, social, and financial effects. Managing all of these effects is called palliative care or supportive care. It is an important part of your care that is included along with treatments intended to slow, stop, or eliminate the cancer.
Palliative care focuses on improving how you feel during treatment by managing symptoms and supporting patients and their families with other, non-medical needs. Any person, regardless of age or type and stage of cancer, may receive this type of care. And it often works best when it is started right after a cancer diagnosis. People who receive palliative care along with treatment for the cancer often have less severe symptoms, better quality of life, and report that they are more satisfied with treatment.
Palliative treatments and care vary widely and often include medication, nutritional changes, relaxation techniques, emotional and spiritual support, and other therapies. You may also receive palliative treatments similar to those meant to get rid of the cancer, such as chemotherapy, surgery, or radiation therapy. Palliative care should not be confused with hospice care, which is used when a cure is not likely or when people are in the last months of life.
Before treatment begins, talk with your doctor about the goals of each treatment in the treatment plan. You should also talk about the possible side effects of the specific treatment plan and palliative care options.
During treatment, your health care team may ask you to answer questions about your symptoms and side effects and to describe each problem. Be sure to tell the health care team if you are experiencing a problem. This helps the health care team treat any symptoms and side effects as quickly as possible. It can also help prevent more serious problems in the future.
Supportive care for people with pancreatic cancer may include:
Palliative chemotherapy. Any chemotherapy regimen discussed above may help relieve the symptoms of pancreatic cancer, such as lessening pain, improving a patient’s energy and appetite, and stopping or slowing weight loss. This approach is used when the cancer has spread and cannot be cured, but the symptoms of the cancer can be improved with chemotherapy. When making decisions about palliative chemotherapy, it is important that you and your doctor weigh the benefits with the possible side effects and consider how each treatment might affect your quality of life.
Relieving bile duct or small intestine blockage. If the tumor is blocking the common bile duct or small intestine, placing a tiny tube called a stent can help keep the blocked area open. This procedure can be performed using nonsurgical approaches, such as ERCP, PTC, or endoscopy (see the Diagnosis section for more information). A stent can be either plastic or metal. The type used depends on the availability, insurance coverage/cost, a person’s expected lifespan, and whether the cancer will eventually be removed with surgery. In general, plastic stents are less expensive and are easier to insert and remove. However, they need to be replaced every few months, are associated with more infections, and are more likely to move out of place. Stents are typically placed inside the body, but sometimes, a tube may need to be placed through a hole in the skin of the abdomen to drain fluid, such as bile. This is called percutaneous drainage. Sometimes, a patient may need surgery to create a bypass, even if the tumor itself cannot be completely removed.
Improving digestion and appetite. A special diet, medications, and specially prescribed enzymes may help a person digest food better if their pancreas is not working well or has been partially or entirely removed. Meeting with a dietitian/nutritionist is recommended for most patients, especially for those who are losing weight and have a poor appetite because of the disease.
Controlling diabetes. Insulin will usually be recommended if a person develops diabetes due to the loss of insulin produced by the pancreas, which is more common after a total pancreatectomy.
Relieving pain and other side effects. Morphine-like drugs called opioid analgesics are often needed to help reduce pain. Special types of nerve blocks done by pain specialists may also be used. One type of nerve block is a celiac plexus block, which helps relieve abdominal or back pain. During a nerve block, the nerves are injected with either an anesthetic to stop pain for a short time or a medication that destroys the nerves and can relieve pain for a longer time. A nerve block can be performed either percutaneously (through the skin) or with an endoscopic ultrasound (see above). Depending on where the tumor is located, radiation therapy can sometimes be used to relieve pain. Learn more about managing pain.
Recommended supportive care may also include complementary therapies. It is important that you talk with your doctor before trying any complementary therapies to make sure they do not interfere with your other cancer treatments.
Palliative and supportive care is not limited to managing a patient’s physical symptoms. There are also emotional issues, like anxiety and depression, and psychological issues that many patients experience and that can be managed with professional help and support. A professional can help with developing coping skills and the overall difficulty of dealing with cancer. Cancer also affects caregivers and loved ones, and they are encouraged to seek out support as well.
Treatment options by stage of pancreatic cancer
Different treatments may be recommended for each stage of pancreatic cancer. Your doctor will recommend a specific treatment plan for you based on the cancer’s stage and other factors. Detailed descriptions of each type of treatment are provided earlier in this page. Clinical trials may also be a treatment option for each stage.
Below are some of the possible treatments based on the stage of the cancer. The information below is based on ASCO guidelines for the treatment of pancreatic cancer. Your care plan may also include treatment for symptoms and side effects, an important part of pancreatic cancer care. Also, patients with any stage of pancreatic cancer are encouraged to consider clinical trials as a treatment option. Talk with your doctor about all of your treatment options. Your doctor will have the best information about which treatment plan is recommended for you.
Potentially curable pancreatic cancer (also called resectable and borderline resectable pancreatic cancer)
Removal of the tumor and nearby lymph nodes if there are no signs that the disease has grown beyond the pancreas or spread to other parts of the body.
Treatment before surgery, also called neoadjuvant therapy or pre-operative therapy
Chemotherapy, with or without radiation therapy, is regularly used for patients with borderline resectable pancreatic cancer. It is done to try to shrink the tumor and increase the chance that the surgeon can remove the tumor with clear margins. Even for people with resectable pancreatic cancer, neoadjuvant therapy is also sometimes recommended.
Treatment after surgery, also called adjuvant therapy or post-operative therapy
Adjuvant chemotherapy usually starts within 4 to 12 weeks after surgery depending on how quickly a patient recovers. It is typically given for a total of 6 months. The type of combination chemotherapy given is usually FOLFIRINOX (5-FU, leucovorin, irinotecan, and oxaliplatin) for those patients who have recovered well from surgery and are healthy enough for a multidrug combination. The alternative option is gemcitabine, either as a single drug or in combination with a second drug called capecitabine. Multidrug combinations have been shown to be more effective than just gemcitabine alone, but are associated with more side effects, including diarrhea, fatigue, neuropathy, low levels of white blood cells, and hand-foot syndrome. Talk with your doctor about the best chemotherapy options for you.
The role of radiation therapy after surgery remains controversial. The option to use radiation therapy after surgery depends on each patient’s situation. For example, it may be an option for when there were not clear margins after surgery.
For patients who received treatment before surgery, the need for additional treatment after surgery depends on each patient’s situation and overall health.
Locally advanced pancreatic cancer
Chemotherapy with a combination of drugs may be an option depending on each patient’s situation and overall health (see options listed under "Metastatic pancreatic cancer" below).
Radiation therapy may also be an option. It is used most often after chemotherapy when the cancer has not spread beyond the pancreas. The choice of the type of radiation therapy used, such as standard external beam or SBRT (see "Radiation therapy" above), depends on several factors, including the size and location of the tumor.
If the disease worsens during or after first-line treatment, options may include trying different chemotherapy. Or, it may be possible to use radiation therapy if the tumor has not spread beyond the pancreas and you have not already received it.
If standard treatment options are not working, you may want to consider a clinical trial. Talk with your doctor about clinical trials that may be open to you.
Metastatic pancreatic cancer (updated 08/2020)
If cancer spreads to another part in the body from where it started, doctors call it metastatic cancer. If this happens, it is a good idea to talk with doctors who have experience in treating it. Doctors can have different opinions about the best standard treatment plan. Clinical trials might also be an option, so talk with your doctor about clinical trials for which you may be eligible. Learn more about getting a second opinion before starting treatment, so you are comfortable with your chosen treatment plan.
Your treatment plan may include a combination of the treatments discussed above. Treatment options for patients with metastatic pancreatic cancer depend heavily on a patient’s overall health, preferences, and support system. People with metastatic pancreatic cancer should be treated by a multidisciplinary team.
Information below is based on the ASCO guideline, “Metastatic Pancreatic Cancer.” Please note that this link takes you to another ASCO website.
Depending on factors including your preferences, characteristics, and your comorbidity profile, first-line options include:
Chemotherapy with a combination of fluorouracil, leucovorin, irinotecan, and oxaliplatin, called FOLFIRINOX.
Gemcitabine plus nab-paclitaxel.
Gemcitabine by itself for patients who are not healthy enough for the more aggressive 2 combinations above.
Occasionally, another gemcitabine-based or fluorouracil-based combination may be used, such as gemcitabine plus cisplatin, gemcitabine plus capecitabine, or FOLFOX.
Second-line options include those listed below. These are generally for when the disease worsens or patients experienced severe side effects during first-line therapy.
Fluorouracil alone or combined with nanoliposomal irinotecan, irinotecan, or oxaliplatin may be recommended based on the overall health of the patient and shared decision making.
Gemcitabine alone or in combination with nab-paclitaxel may be offered.
Pembrolizumab is recommended when the cancer has high microsatellite instability (MSI-high) or mismatch repair deficiency (dMMR). It is important to note that only about 1% of people with pancreatic cancer have MSI-high disease.
Larotrectinib (Vitrakvi) or entrectinib (Rozlytrek) targeted therapy are recommended for any cancer with an NTRK fusion. NTRK fusions are very rare in pancreatic cancer.
Patients who have an inherited BRCA1 or BRCA2 mutation and who have received first-line platinum-based chemotherapy that stopped the cancer from growing or spreading for 16 weeks or more may continue treatment with chemotherapy or receive maintenance therapy with olaparib (Lynparza), a targeted therapy. Maintenance therapy is treatment with the goal of keeping the cancer in remission, and it is an option after shared decision making between the patient and doctor.
Maintenance therapy can also be an option for patients whose disease has not progressed on first-line treatment, but who, due to side effects, may no longer be able to continue with their original treatment. The only approved maintenance therapy is olaparib (Lynparza), which is beneficial in people who have metastatic pancreatic cancer associated with a germline (hereditary) BRCA mutation following first-line platinum-based chemotherapy. For other patients, maintenance therapy might mean simplifying their original chemotherapy regimen. For example, it might be simplified from gemcitabine/nab-paclitaxel to gemcitabine alone, or from FOLFIRINOX to FOLFOX, FOLFIRI, or capecitabine. Learn more about the basics of maintenance therapy.
Supportive, or palliative, care will also be important to help relieve symptoms and side effects. Talk with your doctor as early as possible about the symptoms you are experiencing, your mental well-being, and the social support available to you. Treatment to ease any cancer-related pain or other symptoms will be offered.
For most people, a diagnosis of metastatic cancer is very stressful and difficult. You and your family are encouraged to talk about how you feel with doctors, nurses, social workers, or other members of the health care team. It may also be helpful to talk with other patients, including through a support group.
Remission and the chance of recurrence
A remission is when cancer cannot be detected in the body and there are no symptoms. This may also be called having “no evidence of disease” or NED.
A remission may be temporary or permanent. This uncertainty causes many people to worry that the cancer will come back. It is important to talk with your doctor about the possibility of the cancer returning. Understanding your risk of recurrence and the treatment options may help you feel more prepared if the cancer does return. Learn more about coping with the fear of recurrence.
If the cancer returns after the original treatment, it is called recurrent cancer. Pancreatic cancer may come back in or near the pancreas (called a local or regional recurrence), or elsewhere in the body (distant recurrence, which is similar to metastatic disease).
When this occurs, a new cycle of diagnostic testing will begin again to learn as much as possible about the extent and location of the recurrence. After this testing is done, you and your doctor will talk about the treatment options. The treatment of recurrent pancreatic cancer is similar to the treatments described above and usually involves chemotherapy. Radiation therapy or surgery may also be used to help relieve symptoms. Your doctor may suggest clinical trials that are studying new ways to treat this type of recurrent cancer. Whichever treatment plan you choose, palliative care will be important for relieving symptoms and side effects.
People with recurrent cancer often experience emotions such as disbelief or fear. You are encouraged to talk with your health care team about these feelings and ask about support services to help you cope. Learn more about dealing with cancer recurrence.
If treatment does not work
Recovery from cancer is not always possible. If the cancer cannot be cured or controlled, the disease may be called advanced or terminal.
This diagnosis is stressful, and for many people, advanced cancer is difficult to discuss. However, it is important to have open and honest conversations with your health care team and family and friends to express your feelings, preferences, and concerns. The health care team has special skills, experience, and knowledge to support patients and their families and is there to help. Making sure a person is physically comfortable, free from pain, and emotionally supported is extremely important.
People who have advanced cancer and who are expected to live less than 6 months may want to consider hospice care. Hospice care is designed to provide the best possible quality of life for people who are near the end of life. You and your family are encouraged to talk with the health care team about hospice care options, which include hospice care at home, a special hospice center, or other health care locations. Nursing care and special equipment can make staying at home a workable option for many families. Learn more about advanced cancer care planning.
After the death of a loved one, many people want and need support to help them cope with the loss. Learn more about grief and loss.
The next section in this guide is About Clinical Trials. It offers more information about research studies that are focused on finding better ways to care for people with cancer. Use the menu to choose a different section to read in this guide.